Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure

Anacor Pharmaceuticals, Inc. (ANAC) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/11/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/11/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
07/05/2016 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
06/24/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/24/2016 4 Shapiro Lucy (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 RIEFLIN WILLIAM JL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Disposed/sold 89,000 shares @ $99.25, valued at $8.8M
Disposed/sold 853 shares @ $99.25, valued at $84.7k
Disposed/sold 4,403 options to buy @ $69.4, valued at $305.6k
06/24/2016 4 LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Disposed/sold 794 shares @ $99.25, valued at $78.8k
Disposed/sold 30,000 options to buy @ $6.92, valued at $207.6k
Disposed/sold 24,000 options to buy @ $6.74, valued at $161.8k
Disposed/sold 15,000 options to buy @ $5.2, valued at $78k
Disposed/sold 15,000 options to buy @ $5.11, valued at $76.7k
Disposed/sold 15,000 options to buy @ $14.22, valued at $213.3k
Disposed/sold 4,096 options to buy @ $69.4, valued at $284.3k
06/24/2016 4 Leonard Keith R (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 WIERENGA WENDALL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
Txns: Disposed/sold 794 shares @ $99.25, valued at $78.8k
Disposed/sold 27,000 options to buy @ $25.48, valued at $688k
Disposed/sold 4,096 options to buy @ $69.4, valued at $284.3k
06/24/2016 4 Zane Lee (SVP and Chief Medical Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 BERNS PAUL L (President and CEO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 4 IPPOLITO VINCENT P (EVP & Chief Commercial Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
06/24/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
06/24/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
06/24/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
06/24/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
06/24/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
06/24/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
06/24/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
06/24/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
06/24/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
06/24/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
06/24/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
06/24/2016 8-K Quarterly results
06/24/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
06/08/2016 8-K Form 8-K - Current report
06/07/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
06/03/2016 4 Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
05/26/2016 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
05/26/2016 SC TO-T Form SC TO-T - Tender offer statement by Third Party
05/24/2016 4 Leonard Keith R (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.
05/19/2016 SC14D9C Form SC14D9C - Written communication relating to third party tender offer
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy